H. Lundbeck A/S

In News

Lundbeck inks licence option deal with Contera Pharma - European Biotechnology Magazine

European Biotechnology Magazine - Oct 20, 2025

Novo Nordisk’s Miriam Frieden to lead BD at Lundbeck - BioCentury

BioCentury - Dec 02, 2025

Avadel Pharmaceuticals agrees to sweetened $2.37B takeover bid from Alkermes amid bidding war - The Business Journals

The Business Journals - Nov 19, 2025

H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal - The Wall Street Journal

The Wall Street Journal - Nov 14, 2025

Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine - TradingView — Track All Markets

TradingView — Track All Markets - Nov 13, 2025

Denmark's Lundbeck bets on epilepsy drug with $2.6 bln Longboard deal - Reuters

Reuters - Oct 14, 2024

Zuellig Pharma expands partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in Asia - Sin Chew Daily

Sin Chew Daily - Dec 16, 2025

Lundbeck’s next chapter: from psychiatry to rare neuro - BioCentury

BioCentury - Mar 17, 2025

Brintellix by H. Lundbeck A/S and Takeda Pharmaceuticals America, Inc - Pharmacy Times

Pharmacy Times - Mar 09, 2021

Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline - Business Wire

Business Wire - Oct 14, 2024

Firm Advises Evercore on Longboard Pharmaceuticals’ $2.6 Billion Acquisition by Lundbeck - Wilson Sonsini

Wilson Sonsini - Oct 14, 2024

H. Lundbeck A/S’s Phase III Data Crushes Hope for Alzheimer’s Once Again - BioSpace

BioSpace - Sep 23, 2016

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment